Status:
COMPLETED
Voriconazole (Vfend) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Lead Sponsor:
Pfizer
Conditions:
Systemic Mycosis
Eligibility:
All Genders
Brief Summary
To collect the efficacy and safety informations of voriconazole related to their appropriate use in daily practice.
Detailed Description
All the subjects whom an investigator prescribes the first voriconazole (VFEND) should be registered consecutively until the number of subjects reaches target number in order to extract subjects enrol...
Eligibility Criteria
Inclusion
- Male or Female subjects intend to treat their deep mycosis who are prescribed voriconazole (VFEND) by their Physicians.
Exclusion
- Subject who heve been prescribed voriconazole (VFEND) before.
Key Trial Info
Start Date :
April 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
1002 Patients enrolled
Trial Details
Trial ID
NCT01151085
Start Date
April 1 2006
End Date
May 1 2012
Last Update
August 8 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.